Kissei Pharmaceutical Co., Ltd. (TYO:4547)

Kissei Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 15, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	173,409	164,586	156,266	121,792	117,826	112,984
Market Cap Growth	5.32%	5.32%	28.31%	3.36%	4.29%	-13.03%
Enterprise Value	127,157	122,521	115,492	77,037	78,311	68,996
Last Close Price	4185.00	3845.00	3442.20	2511.84	2355.26	2208.81
PE Ratio	15.26	13.76	14.00	11.57	9.12	21.38
Forward PE	14.46	17.88	14.26	10.90	36.67	28.42
PS Ratio	1.96	1.86	2.07	1.81	1.80	1.64
PB Ratio	0.83	0.78	0.71	0.63	0.58	0.51
P/TBV Ratio	0.84	0.80	0.72	0.63	0.59	0.52
P/FCF Ratio	86.10	81.72	-	-	2677.87	-
P/OCF Ratio	26.59	25.24	-	-	76.86	-
EV/Sales Ratio	1.44	1.39	1.53	1.14	1.20	1.00
EV/EBITDA Ratio	12.24	11.79	13.96	25.97	33.64	14.83
EV/EBIT Ratio	22.02	21.22	28.75	-	-	45.81
EV/FCF Ratio	63.14	60.83	-	-	1779.80	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	0.12	0.12	0.16	0.50	0.70	0.37
Debt / FCF Ratio	0.64	0.64	-	-	37.27	-
Asset Turnover	0.35	0.35	0.31	0.29	0.26	0.28
Inventory Turnover	1.73	1.73	1.56	1.68	1.75	2.17
Quick Ratio	4.68	4.68	4.17	4.79	4.01	3.70
Current Ratio	6.45	6.45	5.92	6.73	5.30	5.10
Return on Equity (ROE)	5.55%	5.55%	5.43%	5.36%	6.17%	2.60%
Return on Assets (ROA)	1.43%	1.43%	1.04%	-0.31%	-0.35%	0.38%
Return on Capital (ROIC)	1.66%	1.66%	1.20%	-0.36%	-0.41%	0.45%
Return on Capital Employed (ROCE)	2.50%	2.50%	1.70%	-	-	0.60%
Earnings Yield	6.90%	7.27%	7.14%	8.64%	10.97%	4.68%
FCF Yield	1.16%	1.22%	-1.84%	-7.21%	0.04%	-3.07%
Dividend Yield	2.91%	2.60%	2.38%	3.19%	2.38%	2.44%
Payout Ratio	41.94%	31.78%	33.35%	29.78%	19.63%	46.83%
Buyback Yield / Dilution	3.62%	3.62%	1.86%	-	1.18%	0.11%
Total Shareholder Return	6.53%	6.22%	4.24%	3.19%	3.56%	2.55%

Updated Feb 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.